NVDA+2.54%AAPL+1.32%GOOGL−1.62%MSFT+0.20%AMZN−0.10%TSM+1.60%SPCX+7.79%META+0.47%
StockVS

NYSE · Healthcare Plans · USD

Elevance Health, Inc. (ELV) Stock Analysis

Elevance Health, Inc. (ELV) is a Healthcare Plans stock listed on NYSE and quoted in US Dollar.

Last Updated: October 21, 2026

ELV

$434.13

−$6.05 (−1.37%)

Oct 21, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare ELV with… →

ELV Key Statistics

As of Oct 21, 2026
Trading
Open
$445.00
Previous Close
$440.18
Day's Range
426.13–450.69
52-Week Range
274.84–450.69
Volume
2.47M
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
0.71
Valuation
Market Cap
$94.15B
P/E Ratio
19.22
Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
14.60
PEG RatioThe P/E ratio divided by the expected earnings growth rate. It puts a high P/E in the context of how fast profits are growing.
1.44
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
0.47
EPS (ttm)Profit attributable to each share over the last twelve months.
22.59
Financials (FY)
Revenue (FY)
$199.13B+12.62%
Net Income (FY)
$5.66B−5.32%
Profit marginThe share of revenue left as profit after all costs and taxes.
2.47%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
216.87M
1-Year Return
+26.59%
Dividend and dates
Dividend
$6.88+1.56%
Ex-Dividend Date
September 10, 2026
Earnings Date
October 21, 2026
Avg Volume
1.12M

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

Key facts

As of October 21, 2026, ELV closed at $434.13, +26.59% over 1 year.

Elevance Health, Inc. (ELV) has a market capitalization of $94.15B.

In fiscal 2025, ELV reported revenue of $199.13B.

ELV Stock Return by Calendar Year

Elevance Health, Inc. (ELV) 10-year return: what $10,000 became

1 year
$10,000 $12,659
+26.59%
5 years
$10,000 $10,852
+8.52%
10 years
$10,000 $40,344
+303.44%

If you had invested $10,000 in Elevance Health, Inc. (ELV) 10 years ago, at the close on October 21, 2016, it would have been worth $40,344 at the close on October 21, 2026: +303.44% in total, +14.97% a year, with dividends reinvested. A historical calculation from closing prices adjusted for splits and dividends, before fees and taxes.

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)+25.66%
2025−3.14%
2024−20.72%
2023−6.89%
2022+11.83%
2021+46.12%
2020+7.74%
2019+16.33%
2018+18.11%
2017+58.72%
2016 (partial year)+13.17%

As of October 21, 2026.

ELV Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$199.13B$5.66B2.8%
2024$176.81B$5.98B3.4%
2023$171.34B$5.99B3.5%
2022$156.60B$5.89B3.8%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$199.13B——$5.66B2.8%
2024$176.81B——$5.98B3.4%
2023$171.34B——$5.99B3.5%
2022$156.60B——$5.89B3.8%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

ELV Dividend History

$6.84+4.9% vs 2024

Dividends per share, 2025 · 4 payments

YearDividends per sharePaymentsChange
2026*$5.163—
2025$6.844+4.9%
2024$6.524+10.1%
2023$5.924+15.6%
YearDividends per sharePaymentsChange
2026 (partial year)$5.163—
2025$6.844+4.9%
2024$6.524+10.1%
2023$5.924+15.6%
2022$5.124+13.3%
2021$4.524+18.9%
2020$3.804+18.7%
2019$3.204+6.7%
2018$3.004+11.1%
2017$2.704+315.4%
2016$0.651—

Most recent payment: $1.72 per share, ex-dividend September 10, 2026. Per-share amounts summed by calendar year from ex-dividend dates. Partial years are shown muted and marked with an asterisk.

ELV Valuation vs Healthcare Plans Median

Median of 11 stocks
MetricELVHealthcare Plans medianvs median
P/E19.2226.3827% below
P/S ratio0.470.3822% above
Profit margin2.47%1.18%1.3 pts above

Medians across 11 Healthcare Plans stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of October 21, 2026.

Recent News

All 20 articles ↓

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

Elevance Health, Inc. (ELV) carries a market capitalisation of $94.15B. It is classified in the Healthcare Plans industry, within the Healthcare sector. Headcount on file is 96,129.

The 52-week range on file runs from $274.84 to $450.69. The most recent close on file for ELV is $434.13, dated October 21, 2026. That is −$6.05 (−1.37%) against the previous close. The latest close sits 57.96% above that 52-week low.

Financial Health

Fiscal 2025 revenue came to $199.13B. Against the prior fiscal year total of $176.81B, that is a change of +12.62%. Net income for the same year was $5.66B. That is −5.32% against the prior fiscal year. Profit margin runs at 2.47%. That is 1.3 percentage points above the Healthcare Plans median of 1.18%. Earnings per share on a trailing basis come to 22.59.

Across the 4 fiscal years on file, revenue moves from $156.60B in 2022 to $199.13B in 2025. Of those 4 years, 4 report positive net income.

Valuation Assessment

On trailing earnings, the shares are priced at 19.22 times earnings. That is 27.13% below the Healthcare Plans median of 26.38. On forward earnings the ratio is 14.6. The PEG ratio, which sets the P/E against expected earnings growth, reads 1.44. Measured against sales, the shares trade at 0.47 times revenue. On price-to-sales that is 22.39% above the Healthcare Plans median of 0.38. The medians here are taken across 11 Healthcare Plans companies that report the metric.

The reported beta is 0.71. Daily returns over the trailing 10 years annualize to a volatility of 31.17%. Over the trailing twelve months the total return is +26.59%. Measured over 10 years, that is +14.97% a year compounded.

Growth & Income

ELV pays a dividend yielding 1.56%. That is 0.5 percentage points below the Healthcare Plans median yield of 2.06%. The indicated annual rate is $6.88 a share. The ex-dividend date on file is September 10, 2026. Dividends are recorded for 11 calendar years; 2026 shows 3 payments totalling $5.16 a share. The year before, 2025, totalled $6.84 a share.

Across the complete calendar years on file, 2017 returned +58.72% and 2024 returned −20.72%. Of the 9 complete calendar years on file, 6 finished higher. So far in 2026 the total return is +25.66%.

Peer Comparison

Elevance Health, Inc. (ELV) operates in the Healthcare Plans industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Elevance Health, Inc. ELV $94.15B 19.2
UnitedHealth Group Incorporated UNH $374.30B 26.8
CVS Health Corporation CVS $119.52B 24.6
The Cigna Group CI $79.88B 12.5

The Healthcare Plans industry average P/E ratio is 26.4x. Elevance Health, Inc. trades at a P/E of 19.2.

Every figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.

Related Healthcare Plans Stocks

UNH

UnitedHealth Group Incorporated

$374.30B

 CVS

CVS Health Corporation

$119.52B

 CI

The Cigna Group

$79.88B

 HUM

Humana Inc.

$51.08B

 CNC

Centene Corporation

$34.16B

 MOH

Molina Healthcare, Inc.

$11.22B
View all Healthcare Plans stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.13T

 JNJ

Johnson & Johnson

$621.22B

 ABBV

AbbVie Inc.

$503.27B

 MRK

Merck & Co., Inc.

$369.78B

 NVS

Novartis AG

$292.58B
View all Healthcare stocks →

About Elevance Health, Inc.

Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, and supplemental health insurance benefits. The company also operates in the pharmacy services business; and markets and offers pharmacy services, including home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services, as well as infusion services and injectable therapies through ambulatory infusion centers. In addition, it provides healthcare related services and capabilities, including specialty care enablement and utilization management support for specialized clinical domains; behavioral health and comprehensive care management services; palliative care services and management; virtual care; and payment integrity, subrogation, clinical data exchange through its HealthOS platform, research and data, reporting and clinical analytics, information technology, and business process support services, as well as manages home health, post-acute institutional management, and durable medical equipment costs; and supports plans in managing home and community-based services. The company provides its services under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brands. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was incorporated in 2001 and is based in Indianapolis, Indiana.

Visit website →